Company announcements, and documented platform and research milestones across pharmaceutical quality, manufacturing and R&D.
We have spent the last decade obsessed with the "brain": the model. The real barrier to AI discovery sits upstream, in the data.
The pharmaceutical industry is currently navigating its most significant transformation since the dawn of the antibiotic era.
The pharmaceutical industry has long been haunted by Eroom’s Law: while computing gets cheaper every year, drug discovery keeps getting slower and more expensive.
The peer-reviewed MDM2 study reported a 21.6% reduction in model error and R² of 0.87, with its pipeline released for independent reproduction.
Lead AI has active collaboration with the National University of Singapore and leading Indonesian research universities.
We speak across the Southeast Asian pharma and biotech scene. Tell us what you're working on.
Bring your challenge.
Let’s find the right next step.